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Objective. To evaluate whether the length of time of rupture of membranes (ROM) in optimally managed HIV-positive women on
highly active antiretroviral therapy (HAART) with low viral loads (VL) is predictive of the risk of mother to child transmission
(MTCT) of the human immunodeﬁciency virus (HIV). Study Methods. A retrospective case series of all HIV-positive women who
delivered at two academic tertiary centers in Toronto, Canada from January 2000 to November 2010 was completed. Results.T w o
hundred and ten HIV-positive women with viral loads <1,000 copies/ml delivered during the study period. VL was undetectable
(<50 copies/mL) for the majority of the women (167, 80%), and <1,000 copies/mL for all women. Mode of delivery was vaginal
in 107 (51%) and cesarean in 103 (49%). The median length of time of ROM was 0.63 hours (range 0 to 77.87 hours) for the
entire group and 2.56 hours (range 0 to 53.90 hours) for those who had a vaginal birth. Among women with undetectable VL, 90
(54%) had a vaginal birth and 77 (46%) had a cesarean birth. Among the women in this cohort there were no cases of MTCT of
HIV. Conclusions. There was no association between duration of ROM or mode of delivery and MTCT in this cohort of 210 virally
suppressed HIV-positive pregnant women.
1.Introduction
In economically developed countries, the human immunod-
eﬁciency virus (HIV) infection is now considered a chronic
disease, with life expectancy approaching that of the general
population [1]. Many HIV-positive women choose to pursue
pregnancies [2]. Management of the HIV-positive pregnant
patient should focus on both decreasing the risk of mother
tochildtransmission(MTCT)andminimizing maternaland
neonatal complications.
The Society of Obstetricians and Gynaecologists of
Canada (SOGC) and American College of Obstetricians and
Gynecologists (ACOG) recommend that elective cesarean
section (cesarean section before labor or rupture of mem-
branes (ROMs) be performed for delivery when viral load is
detectable [3] or greater than 1000 copies/mL [4] as there
is a 12-fold increased risk of MTCT [3, 5]. This is based
on several studies that showed that the combination of
intrapartum zidovudine (ZDV) and elective cesarean section
signiﬁcantly decreased vertical transmission compared to
other delivery modes [6–8]. With the addition of highly
active antiretroviral therapy (HAART), the risk of vertical
transmission has continued to decrease [5].2 Infectious Diseases in Obstetrics and Gynecology
ROM increases fetal exposure to maternal blood and
vaginal ﬂuids, and prolonged duration of ROM has been
shown to be a signiﬁcant risk factor for vertical transmission
[6, 9–11]. Evidence exists that after 4 hours of ROM the
risk of MTCT rises and the protective eﬀect of a cesarean
section is lost [9, 10]. However, these conclusions were
based on studies in which only intrapartum monotherapy
with ZDV was used and maternal VL was not known.
Since the addition of HAART, subsequent research has been
performed to determine if prolonged duration of ROM
remains an important risk factor for vertical transmission.
These studies have demonstrated that there is no increased
risk of transmission with ROM longer than 4 hours and
no protective eﬀect of cesarean section [5, 12]. Given that
postpartum morbidity from cesarean section is potentially
higherinHIV-positivewomen[13],achievingavaginalbirth
in this population is beneﬁcial.
Given the paucity of literature addressing this question,
the objective of this study was to review our experience and
evaluate whether the eﬀe c to fd u r a t i o no fR O Mo rm o d e
of delivery on MTCT still exists among optimally managed
HIV-positive women on HAART.
2. Methods
Following ethical approval, we performed a retrospective
chart review of all HIV-positive women who delivered at
Mount Sinai and St. Michael’s Hospitals in Toronto, Canada,
between January 2000 and November 2010.
W o m e nw e r ed e ﬁ n e da s“ o p t i m a l l ym a n a g e d ”i ft h e y
weretaking antepartum HAARTand had a VL less than 1000
copies/mL at the time of delivery. Thus, eligibility criteria
included pregnant women with a predelivery diagnosis of
HIV, adherence to antepartum HAART, VL less than 1000
copies/mL at the time of delivery, and delivery at either of
the two sites. If a woman had had multiple deliveries during
the time period, the most recent delivery data was collected.
Women not on HAART or with viral loads greater than 1000
copies/mL were excluded.
Information regarding the patient’s age, ethnic back-
ground, gravidity, parity, administration of intravenous
ZDV, time of ROM, time of birth, mode of delivery, and
intrapartum procedures (artiﬁcial rupture of membranes
(AROMs), fetal scalp electrodes) were all recorded from the
antenatal charts and/or from the medical records. The VL
closest to the date of birth was recorded. Duration of ROM
was expressed as total length of time in minutes from time of
ROM to time of birth. The proportion of women receiving
intravenous ZDV, with vaginal birth or cesarean section, and
with any invasive procedures was determined.
All children born to HIV-positive mothers were pre-
scribed a 6-week course of oral zidovudine and referred for
follow-up care in the pediatric HIV clinic, at the Hospital for
SickChildren,inToronto.TherateofMTCTwasdetermined
in collaboration with this clinic.
3. Results
During the study period, 213 HIV-positive women delivered
attheparticipatingcenters.Ofthese,3wereexcludedduetoa
viral load > 1000 copies/m—therefore the ﬁnal study cohort
consisted of 210 women. During the 10-year study period,
the number of HIV-positive pregnant women seeking care
steadily increased over time.
Demographic characteristics are reported in Table 1.T h e
majority of the group (135, 64%) was of African descent.
Eighty (38%) women gave birth to their ﬁrst child. A high
rate (16%) of preterm birth, deﬁned as delivery <37 weeks
gestational age, was observed in our cohort. The average
gestational age at birth was 38 weeks and 2 days with a range
of 24 weeks and 6 days to 41 weeks and 3 days.
Of the 210 women, 200 had a recorded VL prior to
delivery. The other 10 women had a VL recorded as “less
than 1000 copies/mL”. Of those 200 patients with known
VL, the majority of the group (n = 167, 84%) had an
undetectable VL (less than 50 copies/mL) at the time of
delivery. The highest viral load in this cohort was 706
copies/mL. The majority of women (n = 179, 85%) received
adequate intrapartum ZDV, deﬁned as having received a
loading dose followed by 3 hours of maintenance infusion
prior to delivery.
In the entire cohort, 107 women (51%) had a vaginal
birth and 103 (49%) had a cesarean birth. Among women
with cesarean birth, 75 (73%) were performed electively
(prior to labor) and 28 (27%) were performed in labor.
Among women with undetectable VL, 90 (54%) had a
vaginal birth, and 77 (46%) had a cesarean birth.
In this cohort, 46 women had AROM. Of those, 20
women had dilation between 0 and 4cm, 20 had greater than
4cm but less than 10cm, and 6 were ruptured just prior to
delivery. Among the 107 women with a vaginal birth, six had
a vacuum-assisted vaginal delivery and one had a fetal scalp
electrode placed.
The median length of time of rupture of membranes for
the entire cohort was 0.63 hours (0.00–77.87). The median
length of time of rupture of membranes for the vaginal
birth group was 2.56 hours (0.00–53.90) and cesarean birth
group was 0.02 hours (0.00–77.87) (P<0.0001). For those
women with an undetectable VL, the median length of time
of rupture of membranes was 0.62 hours (0.00–77.87) and
for those with a detectable VL was 0.57 hours (0.00–33.63)
(P>0.92). When removing those who were ruptured
less than 0.03 hours (elective cesareans, precipitous vaginal
deliveries, etc.), there were 131 patients whose membranes
were ruptured for 0.05 hours or longer. Their median length
of time of rupture was 3.53 hours (0.05–77.87). In total, 59
(28%) women had rupture of membranes for 4 hours or
longer.Forwomenwhowerelessthan37weeksatthetimeof
delivery, the median length of time of rupture was 0.63 hours
(0.00–77.87), and 0.66 hours (0.00–53.90) for those greater
than 37 weeks. The median lengths of time of rupture and
gestational ages are shown in Figure 1.
There were no cases of MTCT in this cohort of HIV-
positive pregnant women.Infectious Diseases in Obstetrics and Gynecology 3
Table 1: Optimally managed HIV-positive women who delivered
between January 2000 and November 2010.
Characteristic
Mean age 32 years (range 16–43)
Race
African 135 (64%)
Caucasian 23 (11%)
Asian 16 (8%)
Caribbean 17 (8%)
Other 11 (5%)
Missing 8 (4%)
Average gravidity 3
Average parity 1
Gestational Age >37 weeks at delivery 177 (84%)
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Figure 1: Gestational age and median lengths of time of rupture.
4. Discussion
This study suggests that, in a group of 210 optimally
managed HIV-positive women who gave birth over a 10-year
period, increasing the duration of ROM did not increase the
likelihood of MTCT. Since the use of HAART, little has been
published speciﬁcally exploring the role of duration of ROM
and MTCT in optimally managed women [11, 12].
In this cohort of women, the median length of time of
ROM for the entire group was 0.63 hours with a range of 0 to
77.87 hours. A large proportion of the group was ruptured
for minutes only, and when removing those women, the
median increases to 3.53 hours, with a range from 0.05 hours
to 77.87 hours. The median for the undetectable VL women
was similar to the entire group, at 0.65 hours, which follows
since the majority of the group had undetectable VL. It
is clear that some women certainly had ROM longer than
the previously recommended time limit of 4 hours [9, 10],
but given that this recommendation is based on studies
where women were not on HAART and maternal VL was
not known, this recommendation may not apply to women
who are optimally managed. In all of our subgroups, the
range extends outside the 4-hour recommendation without
increasing the association with MTCT.
Previous literature has stated that even in women with
undetectable VL, elective cesarean birth reduces MTCT;
however when adjusted for HAART, the eﬀect was no longer
signiﬁcant[5].InourstudythemediantimesofROMforthe
vaginal (2.56 hours) and cesarean groups (0.02 hours) were
statistically diﬀerent, but neither group had a case of MTCT.
This is consistent with previous literature that for women on
HAART, mode of delivery does not inﬂuence risk of MTCT,
even if the length of time of ROM increased.
The adherence rate for IV ZDV prior to delivery in this
study was 85%, which is similar to rates in other studies
[14]. All women who did not receive adequate IV ZDV
priortodeliveryeitherhadprecipitousdeliveriesoroperative
deliveries for emergency indications (cord prolapse, footling
breech in labor). In the majority of cases, the ZDV was
started on admission using preprinted orders, but delivery
occurred before three hours of maintenance infusion could
be completed.
Our cesarean birth rate was 49%, which is well above the
national average of approximately 26% [15]. This may be
related to several factors. First, the majority of the group was
multiparous, accounting for two-thirds of the women who
underwent cesarean. Many of these women chose to undergo
a repeat cesarean, similar to HIV-negative women in Canada
[14]. Second, some HIV-positive women choose to undergo
an elective cesarean regardless of previous delivery status or
VL [3]. A large proportion of women in this study originate
from resource-poor countries where diﬀerent strategies are
e m p l o y e d ,s u c ha sc e s a r e a nb i r t h ,t op r e v e n tM T C T[ 15].
In our cohort of HIV-positive women, the preterm birth
rate was 16%, which is double the average preterm birth rate
in Canada of 8%. This increased preterm birth rate has been
observedinotherstudiesofHIV-positivewomenonHAART
[5, 16]. In previous work done at one of our institutions,
the preterm delivery rate in a cohort of HIV-positive women
was similar to the control group (in press). Possible reasons
for the increased rate in the current cohort could include
earlier induction of labor for abnormal liver function tests or
preeclampsia, or spontaneous preterm labor. These factors
could also be a contributor to the high cesarean birth rate
observed in this study. More research is urgently required to
further explore these relationships.
Preterm premature rupture of membranes (PPROMs)
in optimally managed HIV-positive women poses a clinical
dilemma for management when weighing the risk of prema-
turity over the risk of MTCT. Our study did not speciﬁcally
address the issue of PPROM; however there was a small
number of preterm patients who were ruptured for greater
than the 4-hour recommendation without a case of MTCT.
Overall though, the median lengths of time of rupture for
both the preterm and term patients were similar. More
studies with a larger number of optimally managed patients
with PPROM are required to further explore this complex
issue.
Traditionally, the use of invasive procedures during labor
in HIV-positive women has been discouraged because of the
potential for increasing MTCT [5–10]. In this study, AROM
was employed for labor induction and during the active
phaseoflaborin46womenwithoutincreasingthelikelihood4 Infectious Diseases in Obstetrics and Gynecology
of vertical transmission. One patient did have a fetal scalp
electrode placed, although this is not typical practice even
amongoptimallymanagedwomenandisnotrecommended.
During the study period of ten years, we observed a
trend of an increasing number of deliveries. There are many
possible reasons for this, including an increase in the pro-
portion of women among HIV-positive persons, changing
immigration patterns, and better long-term management of
HIV resulting in better overall health and an increased desire
for childbearing. Since the introduction of HAART in 1998,
there has been a steady decline in antenatal monotherapy use
in Ontario, with an increasing acceptance of and adherence
to HAART regimens [14]. This also may have resulted in
an increasing number of women who met inclusion criteria
of antenatal HAART use and low VL over time. Given
the number of cases from January to November 2010, the
number for 2011 is projected to be similar to 2008 and 2009.
This study has several strengths. We had a large cohort
of HIV-positive women managed by a small number of
practitioners at only two geographic sites. This resulted
in a cohort of optimally managed and virally suppressed
women, with the majority having undetectable VL and
all having VL less than 1,000 copies/mL. Physicians and
nurses at these two sites have experience in the antenatal
and intrapartum care of these women, which increases
the likelihood of appropriate decision-making regarding
medication use and labor management. Finally, complete
follow-up of children born to women in this study allows
us to evaluate MTCT rates over time. There are also some
limitations. Due to the relatively small proportion of HIV-
positive women delivering in Canada, our ability to examine
larger cohorts of women is limited without employing a
multicentre approach. The size of our cohort prevents us
from determining small diﬀerences in transmission rate. To
more accurately investigate the relationship of duration of
ROM and MTCT of HIV in optimally managed women, a
larger multicenter study would be required.
With no cases of MTCT, we were unable to evaluate
patient-speciﬁc or labor and delivery characteristics predic-
tive of transmission. However, we found no association with
increasing duration of ROM or mode of delivery and MTCT.
It is reassuring that, in the current era and among women
with low VL, allowing length of time of ROM to increase
beyond four hours does not appear to increase the risk of
MTCT.
5. Conclusion
In a cohort of over 200 optimally managed HIV-positive
women on HAART with low VL, there were no cases of
MTCT. Increasing the duration of ROM did not increase
the likelihood of MTCT. Further, MTCT was not related to
mode of delivery. Allowing optimally managed women with
low VL to continue in labor beyond four hours of ROM is
acceptable.Additionalstudieswithlargernumbersofwomen
are important to further evaluate the impact of duration of
ROM and mode of delivery on MTCT among HIV-positive
women in the current era.
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